2016 SIBO Symposium

June 4–5, 2016

Designed for physicians, integrative medicine practitioners and the public. Leading experts discuss the latest lab protocols, evidence-based research, pharmacology, dietary interventions and physical medicine techniques for managing small intestine bacterial overgrowth.

Learn more about the 2016 Symposium

Did you miss the 2015 Symposium? Purchase the recordings


What is SIBO?

Small intestine bacterial overgrowth (SIBO) is a chronic microbial colonization of the small intestine.  These bacteria (and archaea) normally live in the gastrointestinal tract, however, in SIBO they have overgrown in a location not meant for so many microorganisms. They interfere with normal digestion and absorption of food and are associated with damage to the lining of the small intestine. The gases and other by-products of these microorganisms can create many symptoms in the digestive tract, nervous system and other organs.

SIBO: A new clinical approach to IBS and modern health disorders

IBS, one of the most common and difficult-to-treat conditions today, typically has its roots in SIBO. Affecting more than 60 million Americans, IBS symptoms include abdominal pain, bloating, gas, constipation, and/or diarrhea. Research into available therapies for SIBO reveals a high success rate. Until recently many of these patients had very few effective treatment options..

These evidence-based approaches not only manage a significant portion of IBS cases, but also may reduce symptoms of associated disorders, including Crohn’s and other autoimmune diseases, fatigue, restless leg syndrome, diabetes, skin disorders, GERD, and others.

Knowledge of SIBO is growing among patients

The topic of small intestine bacterial overgrowth (SIBO) and the influence of gut flora on brain and general health are hot topics. The national media has turned its spotlight on the human microbiome and its influence on IBS, depression, anxiety, pain, obesity, immune health, and more, with stories appearing in The New York Times, Scientific American, and other major news outlets. SIBO-oriented Facebook pages, books, websites, and products devoted to SIBO diets are blossoming.

Patient demand for medical or holistic guidance is woefully unmet as few practitioners understand the basic principles of SIBO or effective treatments for IBS. Patients need access to testing, pharmaceutical and botanical management, and experienced guidance through qualified health care practitioners.

Expand your clinical knowledge by joining NCNM and the SIBO Center in welcoming the leading experts in the field as they share their knowledge on the relationships among SIBO, IBS, and associated conditions.